176 related articles for article (PubMed ID: 9123121)
1. Neoral without intravenous cyclosporine in liver transplantation.
Hemming AW; Greig PD; Cattral MS; Chung SW; Lilly LB; Aljumah AA; Levy GA
Transplant Proc; 1997; 29(1-2):543. PubMed ID: 9123121
[No Abstract] [Full Text] [Related]
2. Reduced acute rejection and side effects with neoral in liver transplantation.
Tisone G; Vennarecci G; Pisani F; Baiocchi L; Mercadante E; Orlando G; Anselmo A; Casciani CU
Transplant Proc; 1998 Jun; 30(4):1430-1. PubMed ID: 9636579
[No Abstract] [Full Text] [Related]
3. Absorption of cyclosporine Neoral early after liver transplantation: is it possible to abandon intravenous cyclosporine A application?
Haller GW; Winkler M; Bechstein WO; Oldhafer KJ; Ringe B; Maibücher A; Färber L; Pichlmayr R; Neuhaus P
Transplant Proc; 1996 Aug; 28(4):2239-40. PubMed ID: 8769211
[No Abstract] [Full Text] [Related]
4. A meta-analysis to assess the safety and tolerability of two formulations of cyclosporine: Sandimmune and Neoral.
Shah MB; Martin JE; Schroeder TJ; First MR
Transplant Proc; 1998 Dec; 30(8):4048-53. PubMed ID: 9865291
[No Abstract] [Full Text] [Related]
5. Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.
Reggiani P; Rossi G; Latham L; Caccamo L; Gatti S; Maggi U; Melada E; Paone G; Doglia M; Vannelli A; Fassati LR
Transplant Proc; 1998 Aug; 30(5):1855-6. PubMed ID: 9723308
[No Abstract] [Full Text] [Related]
6. Experience with neoral cyclosporine through the oral route in liver transplantation.
Bilbao I; Lazaro JL; Pou L; Charco R; Hildalgo E; Murio E; Margarit C
Transplant Proc; 1998 Jun; 30(4):1432-4. PubMed ID: 9636580
[No Abstract] [Full Text] [Related]
7. Low incidence of acute cellular rejection in liver transplantation with Neoral.
Imventarza O; Lendoire J; Bianco G; Saúl J; Braslavsky G; Trigo P; Cueto G; Duek F; Aziz H
Transplant Proc; 1998 Aug; 30(5):1854. PubMed ID: 9723307
[No Abstract] [Full Text] [Related]
8. Increased dosage requirement and rejection after Neoral conversion in pediatric liver transplant patients.
Cao S; Cox KL; Berquist W; So S; Concepcion W; Monge H; Esquivel CO
Transplant Proc; 1998 Dec; 30(8):4322-4. PubMed ID: 9865373
[No Abstract] [Full Text] [Related]
9. NOF-11: a one-year randomized double-blind comparison of Neoral versus Sandimmune in pediatric liver transplantation.
Alvarez F; Atkison P; Grant D; Jones A; Kim P; Kneteman N; Laurin L; Martin S; Paradis K; Shapiro J; Smith L; Superina R; Tan A
Transplant Proc; 1998 Aug; 30(5):1961. PubMed ID: 9723352
[No Abstract] [Full Text] [Related]
10. Neoral in liver transplantation.
Jamieson NV; Tan L; Jamieson I; Trull A; Gimson AE; Alexander G; Friend PJ; Calne RY
Transplant Proc; 1996 Aug; 28(4):2229-31. PubMed ID: 8769207
[No Abstract] [Full Text] [Related]
11. Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation.
Bilbao I; Pou L; Allende E; Lázaro JL; Charco R; Hidalgo E; Margarit C
Transplant Proc; 2001 May; 33(3):2124-6. PubMed ID: 11377472
[No Abstract] [Full Text] [Related]
12. Reduced acute rejection after liver transplantation with Neoral-based triple immunosuppression.
Mirza DF; Gunson BK; Soonawalla Z; Pirenne J; Mayer AD; Buckels JA; McMaster P
Lancet; 1997 Mar; 349(9053):701-2. PubMed ID: 9078209
[No Abstract] [Full Text] [Related]
13. Cyclosporine versus cyclosporine microemulsion in pediatric liver transplant recipients.
Loss GE; Brady L; Grewal HP; Siegel CT; Mead J; Bruce DS; Cronin DC; Woodle ES; Newell KA; Thistlethwaite JR; Millis JM
Transplant Proc; 1998 Jun; 30(4):1435-6. PubMed ID: 9636581
[No Abstract] [Full Text] [Related]
14. Early use and oral absorption of cyclosporine neoral after liver transplantation.
Kattner A; Ringe B; Haller GW; Kirchner G; Sewing KF; Winkler M
Transplant Proc; 1998 Jun; 30(4):1422-3. PubMed ID: 9636576
[No Abstract] [Full Text] [Related]
15. Low incidence of rejection after synchronous pancreas-kidney transplantation with Neoral.
Cattral MS; Hemming AW; Greig PD; Rowsell C; Chari R; Wright E; Donat D; Cole E; Levy GA
Transplant Proc; 1998 Aug; 30(5):1946. PubMed ID: 9723346
[No Abstract] [Full Text] [Related]
16. Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients.
Melter M; Rodeck B; Kardorff R; Hoyer PF; Maibücher A; Brodehl J
Transplant Proc; 1996 Aug; 28(4):2276-8. PubMed ID: 8769224
[No Abstract] [Full Text] [Related]
17. Neoral reduces the incidence of acute rejection after renal transplantation.
Sandrini S; Setti G; Gaggia P; Chiappini R; Maffeis R; Tardanico R; Maiorca R
Transplant Proc; 1998 Aug; 30(5):1758-9. PubMed ID: 9723269
[No Abstract] [Full Text] [Related]
18. Microemulsion cyclosporine (Neoral) immunosuppression for orthotopic liver transplantation in children reduces hospital stay.
Arumugam R; Soriano HE; Scheimann AO; Reid BS; Gopalakrishna GS; Barakat O; Ozaki CF; Wood RP
Transplant Proc; 1998 Aug; 30(5):1848-9. PubMed ID: 9723304
[No Abstract] [Full Text] [Related]
19. [A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation].
Roy A; Grant DR; Kneteman NM; Tchervenkov JI; Levy GA; Tan A; Hendricks L
Ann Chir; 1998; 52(8):716-21. PubMed ID: 9846420
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus versus cyclosporin microemulsion in liver transplantation: results of a 3-month study.
Mühlbacher F;
Transplant Proc; 2001; 33(1-2):1339-40. PubMed ID: 11267317
[No Abstract] [Full Text] [Related]
[Next] [New Search]
